Eukystol
Disruptive Behavior Disorder
Christian Medical College, Vellore, IndiaSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Disruptive Behavior Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olanzapine Washington University School of Medicine | Phase 4 | BBB |
Risperidone Washington University School of Medicine | Phase 4 | BB |
Guanfacine Maimonides Medical Center | Phase 4 | BB |
Intramuscular Olanzepine Christian Medical College, Vellore, India | Phase 3 | BB |
Promethazine Christian Medical College, Vellore, India | Phase 3 | BB |
View all 10 →
Same molecule, other indications
Eukystol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →